Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Two-Seventy-One Patent Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Two-Seventy-One Patent BlogUSPTO Seeking Comments on Interim Patentable Subjet Matter Guidelines
By Peter Zura
Last Thursday, the USPTO requested comments from the public regarding the Interim Patent Subject Matter Eligibility Examination Instructions. Written comments must be received on or before September 28, 2009. No public hearing will be held.
In case you're wondering why the USPTO has provided a scant 11-day lead time for comments,
[T]he Interim Patent Subject Matter Eligibility Examination Instructions relate only to interpretative rules, general statements of policy, or rules of agency organization, procedure, or practice. The USPTO is providing this opportunity for public comment because the USPTO desires the benefit of public comment on the Interim Patent Subject Matter Eligibility Examination Instructions; however, notice and an opportunity for public comment are not required under 5 U.S.C. 553(b) or any other law. See Cooper Techs. Co. v. Dudas, 536 F.3d 1330, 1336?37, (Fed. Cir. 2008) (stating that 5 U.S.C. 553, and thus 35 U.S.C. 2(b)(2)(B), does not require notice and comment rule making for ?? ?interpretative rules, general statements of policy, or rules of agency organization, procedure, or practice.? ??)Comments should be sent by electronic mail message over the Internet addressed to AB98.Comments@uspto.gov.
Comments may also be submitted by facsimile to (571) 273?0125, marked to the attention of Caroline D. Dennison.
Although comments may be submitted by mail or facsimile, the USPTO prefers to receive comments via the Internet.
Read the notice here (link)
Full post as published by Two-Seventy-One Patent Blog on September 22, 2009 (boomark / email).
Explicit E-Mail
Adult website fined $413,000 in explicit e-mail matter.
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Interim Guidelines on Examining Statutory Subject Matter
USPTO issues new section 101 guidelines for use until Supreme Court decides Bilski v. Doll
Patent Office Would Like Your Opinion 101 Interim Examination Instructions
Bits and Bytes: BRCA Gene Patents
Guidelines on Personal Identifying Data in Court Records
USPTO issues interim instructions to examiners for evaluating patent-eligible subject matter








